American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Arthritis and Rheumatology

Volumn 68, Issue 2, 2016, Pages 282-298

  Ward, Michael M ^a   Deodhar, Atul ^b   Akl, Elie A ^c   Lui, Andrew ^d   Ermann, Joerg ^e   Gensler, Lianne S ^d   Smith, Judith A ^f   Borenstein, David ^g   Hiratzka, Jayme ^b   Weiss, Pamela F ^h   Inman, Robert D ⁱ   Majithia, Vikas ^j   Haroon, Nigil ⁱ   Maksymowych, Walter P ^k   Joyce, Janet ^l   Clark, Bruce M ^m   Colbert, Robert A ^a   Figgie, Mark P ⁿ   Hallegua, David S ^o   Prete, Pamela E ^p   Rosenbaum, James T ^b   Stebulis, Judith A ^q   Van Den Bosch, Filip ^r   Yu, David T Y ^s   Miller, Amy S ^l   Reveille, John D ^t   Caplan, Liron ^u,v   more..

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g PC   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^k UNIVERSITY OF ALBERTA   (Canada)

^l American College of Rheumatology   (United States)

^m Hospital for Special Surgery ^*  (Canada)

ⁿ HOSPITAL FOR SPECIAL SURGERY   (United States)

^o CEDARS SINAI MEDICAL CENTER   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF MASSACHUSETTS   (United States)

^r GHENT UNIVERSITY   (Belgium)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t UNIVERSITY OF TEXAS   (United States)

^u VETERANS AFFAIRS MEDICAL CENTER   (United States)

^v UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; SLOW ACTING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR ALPHA;

ACHILLES TENDON; ADULT; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; BACK; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG CHOICE; DRUG CONTRAINDICATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTIVE SURGERY; ELECTROCARDIOGRAM; ENTHESITIS; ERYTHROCYTE SEDIMENTATION RATE; EVIDENCE BASED PRACTICE; EXERCISE; FALL RISK ASSESSMENT; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERTHERMIC THERAPY; INFLAMMATORY BOWEL DISEASE; IRITIS; MASSAGE; MEDICAL SOCIETY; NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS; OPHTHALMOLOGIST; OSTEOPOROSIS; OSTEOTOMY; PATELLA LIGAMENT; PATIENT COUNSELING; PATIENT EDUCATION; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUADRICEPS TENDON; RANDOMIZED CONTROLLED TRIAL (TOPIC); SACROILIITIS; SCREENING; SELF CARE; SPINE FUSION; SPINE SURGERY; SPONDYLARTHRITIS; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TOPICAL TREATMENT; ULTRASOUND THERAPY; VALVULAR HEART DISEASE; ANTAGONISTS AND INHIBITORS; COMPLICATION; EVIDENCE BASED MEDICINE; HIP REPLACEMENT; RADIOGRAPHY; RHEUMATOLOGY; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING; STANDARDS; UNITED STATES;

ADALIMUMAB; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ETANERCEPT; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; INFLIXIMAB; PHYSICAL THERAPY MODALITIES; RHEUMATOLOGY; SOCIETIES, MEDICAL; SPONDYLARTHRITIS; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 84956589416     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39298     Document Type: Article

References (30)

1. Braun J, Sieper J., Ankylosing spondylitis. Lancet 2007; 369: 1379-90.
2. Zochling J, Smith EU., Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol 2010; 24: 747-56.
3. Perez Alamino R, Maldonado Cocco JA, Citera G, Arturi P, Vazquez-Mellado J, Sampaio-Arros PD, et al., Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 2011; 38: 1656-60.
4. Van der Linden S, Valkenburg HA, Cats A., Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
5. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al., The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-83.
6. Amor B, Dougados M, Mijiyawa M., Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 1990; 57: 85-9. In French.
7. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al, and the European Spondylarthropathy Study Group. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
8. Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al., 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011; 70: 896-904.
9. Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V, et al., Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) 2008; 47: 355-61.
10. Smolen JS, Braun J, Dougados M, Emery P, FitzGerald O, Helliwell P, et al., Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 2014; 73: 6-16.
11. Van den Berg R, Stanislawska-Biernat E, van der Heijde DM., Comparison of recommendations for the use of anti-tumour necrosis factor therapy in ankylosing spondylitis in 23 countries worldwide. Rheumatology (Oxford) 2011; 50: 2270-7.
12. Grade Working Group web site. URL: www.gradeworkinggroup.org.
13. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al, for the GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.
14. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al., GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400.
15. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al., GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-94.
16. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al., GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-6.
17. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, et al., GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 2013; 66: 151-7.
18. Coombes BK, Bisset L, Vincenzino B., Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet 2010; 376: 1751-67.
19. Metcalfe D, Achten J, Costa ML., Glucocorticoid injections in lesions of the Achilles tendon. Foot Ankle Int 2009; 30: 661-5.
20. Wallen M, Gillies D., Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 2006: CD002824.
21. Poddubnyy D, Sieper J., Radiographic progression in ankylosing spondylitis/axial spondyloarthritis: how fast and how clinically meaningful? Curr Opin Rheumatol 2012; 24: 363-9.
22. Baraliakos X, Listing J, Rudwaleit M, Brandt J, Alten R, Burmester G, et al., Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis. J Rheumatol 2007; 34: 510-5.
23. Crofford LJ., Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 2013; 15 Suppl 3: S2.
24. Ravindran V, Scott DL, Choy EH., A systematic review and meta-analysis of efficacy and toxicity of disease-modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis 2008; 67: 855-9.
25. Liao CC, Chen LR., Anterior and posterior fixation of a cervical fracture induced by chiropractic spinal manipulation in ankylosing spondylitis: a case report. J Trauma 2007; 63: E90-4.
26. Loh AR, Acharya NR., Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol 2010; 150: 534-42.
27. Forrest K, Symmons D, Foster P., Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment Pharmacol Ther 2004; 20: 1035-43.
28. Sandborn WJ, Stenson WF, Brynskov J, Lorenz RG, Steidle GM, Robbins JL, et al., Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol 2006; 4: 203-11.
29. Cohen LB, Nanau RM, Delzor F, Neuman MG., Biologic therapies in inflammatory bowel disease. Transl Res 2014; 163: 533-56.
30. Lautermann D, Braun J., Ankylosing spondylitis: cardiac manifestations. Clin Exp Rheumatol 2002; 20 Suppl 28: S11-5.